Activating Mutation in the Receptor Tyrosine Kinase FLT3 with Clinicopathological Relevance in Canine Mast Cell Tumors

<div>Difference in white blood cell (WBC) (a) and neutrophil (b) counts between. FLT3- WT and ITD mutation groups of MCT dogs. Data are presented as dot plots analysis of total WBC counts (a) and neutrophil counts (b) of canine MCT patients between FLT3-WT (<i>n</i> = 4) and FLT3-ITD mutation of JM domain (<i>n</i> = 16).</div>

Veterinary Medicine International

fig2

Figure 2

Figure 2: Activating Mutation in the Receptor Tyrosine Kinase FLT3 with Clinicopathological Relevance in Canine Mast Cell Tumors 